1 / 14

Global Acetic Acid Market will Grow at a CAGR of more than 9% by 2023

Acetic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023,’ states that the market will log more than 9% CAGR through the report’s forecast period

wamy156
Télécharger la présentation

Global Acetic Acid Market will Grow at a CAGR of more than 9% by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Antidiabetics Market Research Report Presented By Market Research Engine http://marketresearchengine.com/

  2. Report TitleGlobal Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022

  3. New York, May 29: Market Research Engine has published a new report titled as “Antidiabetics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022” Ant diabetics are the drugs which stabilize the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of antidiabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels.  Browse Full Report: http://www.marketresearchengine.com/reportdetails/antidiabetics-market Increasing number of diabetic patients is increasing the demand for antidiabetics which is a driving factor for antidiabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.

  4. The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period. The global antidiabetics marketis segmented based on its product which includes thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). This report provides:  1) An overview of the global market for antidiabetics and related technologies. 2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023. 3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.

  5. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry.  REPORT SCOPE:  The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, BoehringerIngelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

  6. The Antidiabetics Market has been segmented as below: By Types of Insulin • Rapid Acting • Long Acting • Premixed • Premixed Analog • Short Acting • Intermediate Acting By Product • Biguanides • Thiazolodinediones • GLP-agonists • Sulphonylureas

  7. • DPP-4 inhibitors • SGLT-2 • Alpha-glucosidase Inhibitors • Meglitinides By Geography • North America • Europe • Asia-Pacific • Rest of the World (ROW)

  8. Table of Contents TABLE OF CONTENT Chapter 1. Executive Summary 1.1. Antidiabetics–Industry Summary and Critical Success Factors (CSFs) Chapter2. Antidiabetics Industry Outlook 2.1. Market Segmentation 2.2. Market sizeand growth prospects 2.3. Antidiabetics – Market dynamics 2.3.1. Market driver analysis 2.3.1.1 Growing prevalence of diabetes 2.3.1.2 Presence of a strong product pipeline portfolio 2.3.1.3 Growing prevalence of lifestyle induced disorderssuch as obesity 2.3.2. Market Restraint Analysis 2.3.2.1. High insulin prices 2.4. KeyOpportunities Prioritized 2.5. IndustryAnalysis – Porter’s 2.6. Antidiabetics– PESTEL analysis

  9. 2.7 Antidiabeticsmarket – Pipeline overview Chapter3 . Antidiabetics Product Outlook 3.1. Antidiabeticsmarket share by product, 2013 & 2020 3.2. Insulin 3.2.1. Insulin market share, by product, 2013 & 2020 3.2.2. Rapid acting analog market 3.2.2.1. Rapid acting analog market, 2012 – 2020 (USDMillion) 3.2.3. Long acting analog market 3.2.3.1 Long acting analog market, 2012 – 2020 (USD Million) 3.2.4. Premixed analog market 3.2.4.1 Premixed analog market, 2012 – 2020 (USD Million) 3.2.5. Premixed insulin market 3.2.5.1. Premixed insulin market, 2012 – 2020 (USD Million) 3.2.6. Short acting insulin market 3.2.6.1. Short acting insulin market, 2012 – 2020 (USDMillion) 3.2.7. Intermediate acting insulin market 3.2.7.1 Intermediate acting insulin market, 2012 – 2020 (USDMillion) 3.3. Otherantidiabetics 3.4. Alphaglucosidase inhibitors 3.4.1. Alpha glucosidase inhibitors market, 2012 – 2020 (USD Million)

  10. 3.5. Biguanides 3.5.1. Biguanides market, 2012 – 2020 (USD Million) 3.6. Sulphonylureas 3.6.1. Sulphonylureas market, 2012 – 2020 (USD Million) 3.7. GLP 1 (Glucagon like peptide) agonists 3.7.1. GLP 1 agonist market, 2012 – 2020 (USD Million) 3.8. DPP - 4(Dipeptyl peptides) inhibitors 3.8.1. DPP-4 market, 2012 – 2020 (USD Million) 3.9. Meglitinides 3.9.1. Meglitinidesmarket, 2012 – 2020 (USD Million) 3.10. SGLT - 2(sodium glucose transport proteins) inhibitors 3.10.1. SGLT - 2 inhibitors market, 2012 – 2020 (USD Million) 3.11. Thiazolodinediones 3.11.1. Thiazolodinediones market, 2012 – 2020 (USD Million) Chapter4. Antidiabetics Regional Outlook 4.1. Antidiabeticsmarket share, by region, 2013 & 2020 4.2. North America antidiabetics market 4.2.1. North America antidiabetics market, 2012 – 2020 (USD Million) 4.3. Europeanti diabetics market 4.3.1. Europe antidiabetics market, 2015 – 2023 (USD Million)

  11. 4.4. Asia Pacificantidiabetics market 4.4.1. Asia Pacific antidiabetics Market, 2015 – 2023(USD Million) 4.5. RoWantidiabetics market 4.5.1. RoWantidiabetics market, 2015 – 2023 (USD Million) Chapter5. Competitive Landscape 5.1 Sanofi Aventis 5.1.1Company Overview 5.1.2Financial Performance 5.1.3Product Benchmarking 5.1.4Strategic Initiatives 5.2 TakedaPharmaceuticals 5.2.1Company Overview 5.2.2Financial Performance 5.2.3Product Benchmarking 5.2.4Strategic Initiatives 5.3 Eli Lilly 5.3.1Company Overview 5.3.2Financial Performance 5.3.3Product Benchmarking 5.3.4Strategic Initiatives

  12. 5.4 OramedPharmaceuticals Inc. 5.4.1Company Overview 5.4.2Financial Performance 5.4.3Product Benchmarking 5.4.4Strategic Initiatives 5.5 Merck & Co. Inc. 5.5.1Company Overview 5.5.2Financial Performance 5.5.3Product Benchmarking 5.5.4Strategic Initiatives 5.6 Novo Nordisk 5.6.1Company Overview 5.6.2 FinancialPerformance 5.6.3Product Benchmarking 5.6.4Strategic Initiatives 5.7 Bristol-Myers Squibb 5.7.1Company Overview 5.7.2Financial Performance 5.7.3Product Benchmarking 5.7.4Strategic Initiatives 5.8 Halozyme Therapeutics

  13. 5.8.1Company Overview 5.8.2Financial Performance 5.8.3Product Benchmarking 5.8.4Strategic Initiatives 5.9 Pfizer 5.9.1Company Overview 5.9.2Financial Performance 5.9.3Product Benchmarking 5.9.4Strategic Initiatives Check Out Other Research Reports: 5G Technology Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 http://www.marketresearchengine.com/reportdetails/5g-technology-market Acetic Acid Market for VAM, PTA, Acetate Esters, Acetic Anhydride and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023http://www.marketresearchengine.com/reportdetails/acetic-acid-market

  14. About Market Research Engine Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. More info: http://marketresearchengine.com/ Media Contact: Name: John Bay Toll Free No.: +1-855-984-1862 Phone: +91-860-565-7204 Email:john@marketresearchengine.com Website:http://marketresearchengine.com/

More Related